Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  5,370 results for ""VACCINES""

Your Filters

Publisher : bmj publishing group Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination.

Subjects: ADP-ribosyl Cyclase 1*/ADP-ribosyl Cyclase 1*/ADP-ribosyl Cyclase 1*/immunology ; Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/immunology ; Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/drug therapy

  • Source: Journal of neurology, neurosurgery, and psychiatry [J Neurol Neurosurg Psychiatry] 2024 Aug 16; Vol. 95 (9), pp. 855-864. Date of Electronic Publication: 2024 Aug 16.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 2985191R Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort study.

  • Authors : Ørbo HS; Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway .; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*

  • Source: RMD open [RMD Open] 2024 Apr 09; Vol. 10 (2). Date of Electronic Publication: 2024 Apr 09.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Research ethics and public trust in vaccines: the case of COVID-19 challenge trials.

  • Authors : Eyal N; Center for Population-Level Bioethics, Department of Philosophy (SAS) and Department of HBSP (SPH), Rutgers University, New Brunswick, New Jersey, USA .

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*; Humans

  • Source: Journal of medical ethics [J Med Ethics] 2024 Mar 20; Vol. 50 (4), pp. 278-284. Date of Electronic Publication: 2024 Mar 20.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 7513619 Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Is vaccine response to SARS-CoV-2 preserved after switching to anti-CD20 therapies in patients with multiple sclerosis or related disorders?

  • Authors : Jeantin L; Department of Neurology, Pitié-Salpêtrière University Hospital, AP-HP, Paris, France.; Abdi B

Subjects: Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/drug therapy ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*

  • Source: Journal of neurology, neurosurgery, and psychiatry [J Neurol Neurosurg Psychiatry] 2023 Dec 14; Vol. 95 (1), pp. 19-28. Date of Electronic Publication: 2023 Dec 14.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 2985191R Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Analysis of the institutional landscape and proliferation of proposals for global vaccine equity for COVID-19: too many cooks or too many recipes?

Subjects: COVID-19* ; Vaccines*; Humans

  • Source: Journal of medical ethics [J Med Ethics] 2023 Aug; Vol. 49 (8), pp. 583-590. Date of Electronic Publication: 2021 Nov 30.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 7513619 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Facilitators and barriers for vaccination in patients with inflammatory rheumatic musculoskeletal diseases: a prospective cohort study.

  • Authors : Andreica I; Ruhr University Bochum, Bochum, Germany.; Rheumazentrum Ruhrgebiet, Herne, Germany.

Subjects: Influenza, Human*/Influenza, Human*/Influenza, Human*/epidemiology ; Influenza, Human*/Influenza, Human*/Influenza, Human*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/epidemiology

  • Source: RMD open [RMD Open] 2023 Jun; Vol. 9 (2).Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Trivalent and quadrivalent seasonal influenza vaccine in adults aged 60 and older: a systematic review and network meta-analysis.

  • Authors : Veroniki AA; Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada .; Knowledge Translation Program, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada.

Subjects: Influenza Vaccines*/Influenza Vaccines*/Influenza Vaccines*/administration & dosage ; Influenza Vaccines*/Influenza Vaccines*/Influenza Vaccines*/adverse effects ; Influenza, Human*/Influenza, Human*/Influenza, Human*/prevention & control

  • Source: BMJ evidence-based medicine [BMJ Evid Based Med] 2024 Jul 23; Vol. 29 (4), pp. 239-254. Date of Electronic Publication: 2024 Jul 23.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101719009 Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Report

Petechial skin rash associated with CoronaVac vaccination: first cutaneous side effect report before phase 3 results.

  • Authors : Cebeci F; Department of Dermatology, Istanbul Medeniyet University, Istanbul, Turkey .; Kartal İ

Subjects: Exanthema* ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: European journal of hospital pharmacy : science and practice [Eur J Hosp Pharm] 2023 Jan; Vol. 30 (1), pp. e1. Date of Electronic Publication: 2021 May 24.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101578294 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease.

  • Authors : Frommert LM; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.; Arumahandi de Silva AN

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines* ; Rheumatic Diseases*/Rheumatic Diseases*/Rheumatic Diseases*/drug therapy

  • Source: RMD open [RMD Open] 2022 Dec; Vol. 8 (2).Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapy.

  • Authors : Syversen SW; Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway .; Jyssum I

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects; Humans

  • Source: RMD open [RMD Open] 2022 Nov; Vol. 8 (2).Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
  • 1-10 of  5,370 results for ""VACCINES""